Trial intelligence / Profile preview

Continuous sciatic/posterior tibial nerve blockade in lower limb amputees

2007-000619-27Phase 4Terminated

Sponsor
University Hospitals of Leicester NHS Trust
Start
May 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of levobupivacaine in phantom limb pain (PLP), Residual limb pain (RLP) and phantom limb sensation (PLS) (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoints: Late stump pain at 12 months, Phantom limb pain at 12 months and 1 more. Started May 2007; status: terminated.

02

Drugs

levobupivacaine
03

Conditions

phantom limb pain (PLP)Residual limb pain (RLP)phantom limb sensation (PLS)

Beyond the preview

Go deeper on 2007-000619-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000619-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call